Research
Electron micrograph of an NK cell
The main interest of the
lab currently focusses on the development, recognition capabilities,
and
function of NK [natural killer] cells. NK cells are a major
population
of lymphocytes found in humans and all vertebrate animals. They
play
a critical role in defence against infectious disease, having the
ability
to recognize and kill cells infected with a variety of viruses, and
also being major contributors
to the early production of cytokines following infection with
viruses
and other parasites. It
is also clear that NK cells participate in the rejection of
transplanted
tissues, especially transplanted bone marrow and lymphoid cells, and in
certain autoimmune diseases. Their ability to spontaneously kill
tumour
cells in vitro suggests
that they may protect animals against malignant disease and that it may
be possible to harness NK cells therapeutically for the treatment of
cancer,
a proposition supported by numerous studies showing that NK cell
depletion
causes reduced resistance to tumour growth.
A major advance in our
understanding
of NK cells was the discovery that they employ a novel form of
recognition,
known as “missing self” recognition, that allows them to detect
diseased
or infected cells that have reduced expression of MHC class I
molecules.
At the molecular level
this is achieved via the expression on NK cells of at least three
families
of receptors for class I molecules, the CD94/NKG2 family [which is
present on NK cells from all species] and either the Ly49 family [which
is expressed in rodents and certain other species] or the KIR family
[which is expressed in humans and other primates]. Despite
appearing to have identical functions, the
Ly49 and KIR receptors have radically different structures, the former
belonging to the C-type lectin superfamily and the latter to the Ig
superfamily, providing one of the most remarkable examples of
convergent evolution yet uncovered. MHC class I receptors are not
expressed in the normal codominant manner, but in an unsusual and
poorly
understood stochastic manner, such that each individual NK cell
expresses at random a limited number of all of the class I receptors in
its genome, creating a large and complex repertoire of NK cells in
which to a first approximation each NK cell has a different permutation
of class I receptors. NK cells also express
many other receptors, such as those belonging to the NKRP1, CLR, and
NCR families. Despite
intensive investigation, the processes involved in the creation of this
diverse NK cell repertoire are still poorly understood. Most
available
evidence supports a model in which the stochastic expression of Ly49,
KIR,
and CD94 receptors is triggered at a critical stage in
development.
This creates a naive repertoire that is subjected to “positive and
negative”
selection, resulting in the loss or anergization of those cells that
fail
to express any receptors for self class I molecules, and allowing the
maturation
of those cells that express at least one receptor for self class I
molecules, a phenomenon, sometimes
referred to as "education" or "licencing".
The research performed
in our laboratory in the University of Newcastle has led to significant
advances in our
understanding of NK cells and the receptors they bear. Some of
our main findings have been:
- The discovery that the fetal thymus is a rich source of NK cell
progenitors, making it possible to study the differentiation
and
development
of NK cells from fetal progenitors in vitro, and which also provided
the first, and still only, method for
generating
long-lived
clones of NK cells from normal mice. Brooks et al. J.
Immunol. 1993; Manoussaka et
al. J. Immunol. 160, 2197, 1998; Fraser et al. Eur.
J. Immunol. 2002
- The discovery of the early and potentially critical expression of
Ly49E
during NK cell development. Toomey
et al. Eur.J.Immunol. 28, 47, 1998; Fraser et al. Eur.
J. Immunol. 2002
- The discovery that CD94/NKG2 receptors are responsible for the
ability of fetal NK cells to recognize MHC class I deficient
cells. Toomey
et al. J. Immunol. 163, 3176, 1999
- The discovery that the widely used EL4 and RMA tumour cell lines
display
mosaic expression of various surface molecules and that RMA and several
other commonly used tumour cell lines are in fact all sublines of
EL4. Gays
et al. J. Immunol. 2000
- The definition of the cellular and molecular requirements for
Qa1-mediated
protection of target cells from lysis by NK cells bearing CD94/NKG2A
receptors. Gays et al. J.
Immunol. 2001
- The demonstration that soluble IL2 and IL15 are unlikely to act
alone
to
promote the growth and differentiation of NK cells in vivo, and most
likely
do so only in association with addition factors, in particular
IL21. Toomey
et al. J. Leuk. Biol. 2003
- The discovery that, uniquely amongst Ly49 receptors, Ly49E can be
induced
by IL2 or IL15 on mature NK cells, and that the expression of several
other
NK cell receptors on mature NK cells can be regulated by cytokines. Gays et al. J.
Immunol. 2005
- The discovery that Ly49B is not normally expressed on NK cells
but
instead
is expressed on various subpopulations of myeloid cells where it forms
a constitutive association with the inositol phosphatase SHIP-1,
suggesting
that it may play an important role in preventing spontaneous activation
of myeloid cells in vivo. Gays et al. J.
Immunol. 2006
- The demonstration that NKRP1D expression is limited to a
subpopulation of NK cells, but in contrast to Ly49 receptors is
expressed in a normal codominant manner. Aust et al. J.
Immunol. 2009
- The discovery that NKRP1D+ NK cells are functionally distinct
from NKRP1D- NK cells,
NKRP1D+ cells showing reduced expression of various Ly49 receptors,
elevated expression of CD94/NKG2 receptors, and higher IFN-γ secretion
and cytotoxicity than NKRP1D- cells. Aust et al. J.
Immunol. 2009
- The demonstration through the creation of Ly49E-knockout mice,
that, despite its early expression on immature NK cells, Ly49E is not
required for the development or homeostasis of NK and T cell
populations or for the acquisition of functional competence in NK
cells. Aust
et al. J. Immunol. 2011
- The demonstration that functionally distinct members of the Ly49
family show distinct patterns of transcriptional initiation. Gays
et al. Plos One 2011
Our work has been funded by a series of grants from the Medical
Research
Council, the Biotechnology and Biological Sciences Research Council,
the
Cancer Research Campaign, and the University of Newcastle.
We have collaborated with many scientists in Newcastle, elsewhere in
the
U.K., and in other countries.

High power view of an NK cell granule
containing
perforin, granzymes, and other mediators